首页> 美国卫生研究院文献>International Journal of Nanomedicine >Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review
【2h】

Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review

机译:主动靶向纳米颗粒递送系统在化疗药物和传统/中草药中的应用在癌症治疗中的系统评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Patients treated with conventional cancer chemotherapy suffer from side effects of the drugs due to non-selective action of chemotherapeutic drugs to normal cells. Active targeting nanoparticles that are conjugated to targeting ligands on the surface of nanoparticles play an important role in improving drug selectivity to the cancer cell. Several chemotherapeutic drugs and traditional/herbal medicines reported for anticancer activities have been investigated for their selective delivery to cancer cells by active targeting nanoparticles. This systematic review summarizes reports on this application. Literature search was conducted through PubMed database search up to March 2017 using the terms nanoparticle, chemotherapy, traditional medicine, herbal medicine, natural medicine, natural compound, cancer treatment, and active targeting. Out of 695 published articles, 61 articles were included in the analysis based on the predefined inclusion and exclusion criteria. The targeting ligands included proteins/peptides, hyaluronic acid, folic acid, antibodies/antibody fragments, aptamer, and carbohydrates/polysaccharides. In vitro and in vivo studies suggest that active targeting nanoparticles increase selectivity in cellular uptake and/or cytotoxicity over the conventional chemotherapeutic drugs and non-targeted nanoparticle platform, particularly enhancement of drug efficacy and safety. However, clinical studies are required to confirm these findings.
机译:由于化疗药物对正常细胞的非选择性作用,接受常规癌症化学疗法治疗的患者会遭受药物的副作用。与纳米颗粒表面上的靶向配体缀合的活性靶向纳米颗粒在提高药物对癌细胞的选择性方面起着重要作用。已经报道了报道的几种具有抗癌活性的化学治疗药物和传统/中草药通过主动靶向纳米粒子选择性地递送至癌细胞。本系统综述总结了有关此应用程序的报告。截至2017年3月,通过PubMed数据库搜索进行了文献搜索,使用了纳米粒子,化学疗法,传统药物,草药,天然药物,天然化合物,癌症治疗和主动靶向等术语。在695篇已发表的文章中,根据预定义的纳入和排除标准,分析中包括61篇文章。靶向配体包括蛋白质/肽,透明质酸,叶酸,抗体/抗体片段,适体和碳水化合物/多糖。体外和体内研究表明,与常规化疗药物和非靶向纳米颗粒平台相比,活性靶向纳米颗粒可提高细胞摄取和/或细胞毒性的选择性,特别是增强药物功效和安全性。但是,需要临床研究来证实这些发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号